Tetsuo Ashizawa
Study Director · Houston Methodist Hospital
Credentials: · · ·
History
- 1979–1981
Nephrology
- 1973–1976
/ University Hospital
- 1969–1973
Doctor of Medicine
Research
Nature Genetics · 1997 · 1,337 citations
An unstable triplet repeat in a gene related to myotonic muscular dystrophy
Science · 1992 · 1,319 citations
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
JAMA · 2006 · 407 citations
44 papers
33 papers
31 papers
30 papers
29 papers
29 papers
29 papers
27 papers · 9 as a resident
Grants
- 2018–2024
Supplementary Funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (“READISCA”)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $6.1M · Methodist Hospital Research Institute
- 2019–2024
Genetic Mechanism of Conserved Ancestral Haplotype in SCA10
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $636.5K · Methodist Hospital Research Institute
- 2019
National Institute of Neurological Disorders and Stroke · R13
Contact PI · $20K · Methodist Hospital Research Institute
- 2013–2019
RNA-Gain-of-Function Pathogenesis in SCA10
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Methodist Hospital Research Institute
Clinical trials
- 1999–2009
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Principal investigator · Completed
Office of Rare Diseases (ORD)
- 2018–2023
Clinical Trial Readiness for SCA1 and SCA3
Study chair · Unknown
The Methodist Hospital Research Institute